Clinical Trials Directory

Trials / Conditions / Localized Unresectable Neuroblastoma

Localized Unresectable Neuroblastoma

13 registered clinical trials studyying Localized Unresectable Neuroblastoma.

StatusTrialSponsorPhase
Active Not RecruitingResponse and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neurobla
NCT02176967
Children's Oncology GroupPhase 3
CompletedInduction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Ne
NCT01175356
Children's Oncology GroupPhase 1
CompletedPharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma
NCT01418495
National Cancer Institute (NCI)—
CompletedPrognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma
NCT01358617
Children's Oncology Group—
CompletedVorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
NCT01208454
National Cancer Institute (NCI)Phase 1
CompletedStudy of Specimens From Young Patients With Neuroblastoma
NCT00958659
Children's Oncology Group—
CompletedComparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Tran
NCT00567567
Children's Oncology GroupPhase 3
CompletedStudy of DNA in Blood Samples From Patients With Neuroblastoma
NCT00898391
Children's Oncology Group—
CompletedGenetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
NCT00436696
Children's Oncology Group—
CompletedCyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Childre
NCT00033293
Children's Oncology GroupPhase 3
CompletedR(+)XK469 in Treating Patients With Advanced Neuroblastoma
NCT00028522
National Cancer Institute (NCI)Phase 1
CompletedIsotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Trea
NCT00026312
National Cancer Institute (NCI)Phase 3
Active Not RecruitingBiomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241
Children's Oncology Group—